Automating Titrations: Data Review to Implementation
Nov 14, 2019
P.A.C.E. CE contact hours: 1 hour
Duration: 42 minutes
Titration studies are integral to the standard of care for perinatal evaluation of patients who have become alloimmunized with an antibody of potential clinical significance. Nevertheless, antibody titrations in blood banking have not yet been standardized. Variability across gel and tube testing methods, and in the interpretation of clinical outcomes based on titration endpoints, poses a significant challenge. Automating testing can help deliver more consistent results, helping to provide a reliable tool with which physicians can guide the most appropriate patient care.
In this three part presentation, industry experts address:
Part 1: Prenatal Antibody Titers by ID-MTS™ Gel Test (Back to the Future)
Explore the clinical outcomes associated with performing titration studies using the ID-MTS™ Gel Test method.
Part 2: Improved Standardization of Titrationsn
Explore the process improvements associated with performing titration studies using the ID-MTS™ Gel Test method.
Part 3: Implementation of a Titration Method Change
Gain insights and best practices for developing a validation plan and the successful implementation in moving to automated gel titers in the transfusion service laboratory
This program is P.A.C.E. accredited. Users who watch the video and complete the accompanying quiz will receive credit for 1 hour. P.A.C.E. continuing education credits are only available in the US.
This promotional educational activity is brought to you by Ortho Clinical Diagnostics and is not certified for Continuing Medical Education (CME). The speakers are presenting on behalf of Ortho Clinical Diagnostics and must present information in accordance with applicable and/or local regulatory country requirements.
About Our Speakers:
About Our Speakers:
Laura Cooling, MD, MS
University of Michigan Medical School, Ann Arbor, Michigan
Dr. Cooling received a BS, a MSc from the University of Iowa and an MD from the University of Iowa Medical School. She completed her residence training in Laboratory Medicine followed by a Fellowship in Transfusion Medicine and Pathology at the University of Iowa Hospitals and Clinics. Upon completion of her training, Dr. Cooling served as a Clinical Associate in the Department of Pathology at the University of Iowa Hospitals and Clinics and later as Assistant Professor at State University of New York Health Science Center at Syracuse. She accepted a position as Clinical Assistant Professor at the University of Michigan Medical School in 2000. Dr. Cooling serves as Associate Director of the Department of Pathology's Blood Bank & Transfusion Service. Dr. Cooling is board certified in Clinical Pathology and Transfusion Medicine. She participated in the first study comparing the current tube method with the gel method, which was presented at AABB in 2001.
Dr. Cooling received a BS, a MSc from the University of Iowa and an MD from the University of Iowa Medical School. She completed her residence training in Laboratory Medicine followed by a Fellowship in Transfusion Medicine and Pathology at the University of Iowa Hospitals and Clinics. Upon completion of her training, Dr. Cooling served as a Clinical Associate in the Department of Pathology at the University of Iowa Hospitals and Clinics and later as Assistant Professor at State University of New York Health Science Center at Syracuse. She accepted a position as Clinical Assistant Professor at the University of Michigan Medical School in 2000. Dr. Cooling serves as Associate Director of the Department of Pathology's Blood Bank & Transfusion Service. Dr. Cooling is board certified in Clinical Pathology and Transfusion Medicine. She participated in the first study comparing the current tube method with the gel method, which was presented at AABB in 2001.
About Our Speakers:
Robert Witkowski, PhD
Principal Scientist, Research and Development
Ortho Clinical Diagnostics
Dr. Witkowski, a Principal Scientist in Research and Development at Ortho Clinical Diagnostics, has over 20 years of industry leadership experience in designing and developing clinical diagnostic products and automated systems to commercialization, including the ORTHO VISION Platform.
Dr. Witkowski, a Principal Scientist in Research and Development at Ortho Clinical Diagnostics, has over 20 years of industry leadership experience in designing and developing clinical diagnostic products and automated systems to commercialization, including the ORTHO VISION Platform.
About Our Speakers:
Christina Gendron, MLS (ASCP)
Senior Medical Technologist
Florida Hospital Orlando, Orlando, Florida
Christina Gendron was a Senior Medical Technologist in the Transfusion Service at Florida Hospital when she played a key role in implementing the ORTHO VISION® platform at Florida Hospital, including the automated titration tests with ID-MTS gel.
Christina Gendron was a Senior Medical Technologist in the Transfusion Service at Florida Hospital when she played a key role in implementing the ORTHO VISION® platform at Florida Hospital, including the automated titration tests with ID-MTS gel.
